Skip to content

Clinical trials

Completed Agammaglobulinemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Agammaglobulinemia Status: Completed Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20061
20102
20121
20142
20161
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kedrion S.p.A.2
National Institute of Allergy and Infectious Diseases (NIAID)2
Bio Products Laboratory1
Brigham and Women's Hospital1
CSL Behring1
Columbia University1
Grifols Therapeutics LLC1
M.D. Anderson Cancer Center1
Octapharma1
The Cleveland Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Agammaglobulinemia13
Immunologic Deficiency Syndromes4
Primary Immunodeficiency Diseases4
Common Variable Immunodeficiency3
Infections3
Leukemia, Lymphocytic, Chronic, B-Cell2
Neutropenia2
Warts2
Wiskott-Aldrich Syndrome2
Arthritis, Infectious1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.